Pharmaceuticals publications
Zobrazit stránku: ČeskyPwC has published numerous publications on a number of pharmaceutical topics.
All PwC Pharmaceutical Publications see on PwC Global web site.
Global publications
 |
Holding the lead: First-quarter life sciences venture capital investment declines from previous period but rises year over year; sector still captures largest share of funding Venture capital funding for the life sciences sector rose year over year during the first quarter of 2010 but declined from the previous quarter, according to findings from the MoneyTree™ Report by PwC and the National Venture Capital Association (NVCA), based on data from Thomson Reuters. April 2010 | Free download
|
 |
Insights for pharmaceutical and life science companies: Staying ahead of IFRS challenges Tax policy, research collaborations, mergers and acquisitions, financial planning, systems requirements, and compensation structures are among areas that will bear the impact. In this paper, we address these and other accounting and business challenges stemming from the move to IFRS and outline how PLS companies can begin dealing with them today. March 2010 | Free download
|
 |
Under recovery? - Life sciences venture capital funding overcomes record lows, outpaces other sectors Companies in the Life Sciences sector, which includes the biotechnology and medical device industries, captured the largest share of overall venture capital during 2009, reflecting the relative strength of the sector during the economic downturn.This year in review summary includes where venture capital investments and funding were made, the nature of transactions that took place as well as the geographic distribution of funding for the biotechnology and medical device sectors during 2009. 2010 | Free download
|
 |
Pharma 2020: Taxing times ahead The fifth paper in the series, Pharma 2020: Taxing times ahead, focusses on the challenges ahead but also shows how companies can adapt their tax planning to support the provision of outcomes-based healthcare and remain competitive. November 2009 | Free download
|
 |
Pharma 2020: Challenging business models Fourth in the Pharma 2020 series, this report explains why Pharma's fully integrated business models may not be the best option for the pharma industry in 2020 and why more creative collaboration models may be more attractive. The paper also evaluates the advantages and disadvantages of the alternative business models and how each stands up against the challenges facing the industry. April 2009 | Free download
|
 |
Pharma 2020: Marketing the future - Which path will you take?This paper discusses how the industry is no longer being rewarded for incremental innovation, me-too products and selling the most pills.Companies need to add value to patients, and offer a package of products and health services that the market is willing to pay a premium for.
February 2009 | Free download
|
 |
Pharma 2020: Virtual R&D The second paper in the PwC Pharma 2020 series, explores how pharma companies could dramatically improve the R&D productivity. It contends that by 2020 the R&D process may be shortened by two-thirds, success rates may dramatically increase, and clinical trial costs could be cut substantially. New computer based technologies will create a greater understanding of the biology of disease and the evolution of "Virtual man"; to enable researchers to predict the effects of new drug candidates before they enter human beings. Along with changes underway in the regulatory and socio-political environment, this will enable Pharma to overcome one of the most fundamental issues it needs to resolve over the next decade. June 2008 | Free download
|
 |
Pharma 2020: The vision - Which path will you take? indicates that the current pharmaceutical industry business model is both economically unsustainable and operationally incapable of acting quickly enough to produce the types of innovative treatments demanded by global markets. In order to make the most of these future growth opportunities, the industry must fundamentally change the way it operates. June 2007 | Free download
|
